CLC number:
On-line Access: 2022-03-09
Received: 2021-02-01
Revision Accepted: 2021-08-17
Crosschecked: 0000-00-00
Cited: 0
Clicked: 4072
Gaoying WANG, Jintao YUAN, Ji LUO, Dickson Kofi Wiredu OCANSEY, Xu ZHANG, Hui QIAN, Wenrong XU, Fei MAO. Emerging role of protein modification in inflammatory bowel disease[J]. Journal of Zhejiang University Science B,in press.Frontiers of Information Technology & Electronic Engineering,in press.https://doi.org/10.1631/jzus.B2100114 @article{title="Emerging role of protein modification in inflammatory bowel disease", %0 Journal Article TY - JOUR
蛋白质修饰在炎症性肠病中作用研究进展关键词组: Darkslateblue:Affiliate; Royal Blue:Author; Turquoise:Article
Reference[1]AnanthakrishnanAN, 2015. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol, 12(4):205-217. [2]BaezaJ, SmalleganMJ, DenuJM, 2016. Mechanisms and dynamics of protein acetylation in mitochondria. Trends Biochem Sci, 41(3):231-244. [3]Barbier-TorresL, DelgadoTC, García-RodríguezJL, et al., 2015. Stabilization of LKB1 and Akt by neddylation regulates energy metabolism in liver cancer. Oncotarget, 6(4):2509-2523. [4]BaumgartDC, CardingSR, 2007. Inflammatory bowel disease: cause and immunobiology. Lancet, 369(9573):1627-1640. [5]BrownSJ, MillerAM, CowanPJ, et al., 2004. Altered immune system glycosylation causes colitis in α1,2-fucosyltransferase transgenic mice. Inflamm Bowel Dis, 10(5):546-556. [6]CarusoR, MarafiniI, FranzèE, et al., 2014. Defective expression of SIRT1 contributes to sustain inflammatory pathways in the gut. Mucosal Immunol, 7(6):1467-1479. [7]ColganSP, TaylorCT, 2010. Hypoxia: an alarm signal during intestinal inflammation. Nat Rev Gastroenterol Hepatol, 7(5):281-287. [8]CoskunM, OlsenJ, SeidelinJB, et al., 2011. MAP kinases in inflammatory bowel disease. Clin Chim Acta, 412(7-8):513-520. [9]CurtisVF, EhrentrautSF, ColganSP, 2015a. Actions of adenosine on cullin neddylation: implications for inflammatory responses. Comput Struct Biotechnol J, 13:273-276. [10]CurtisVF, EhrentrautSF, CampbellEL, et al., 2015b. Stabilization of HIF through inhibition of Cullin-2 neddylation is protective in mucosal inflammatory responses. FASEB J, 29(1):208-215. [11]DalmassoG, NguyenHTT, FaïsT, et al., 2019. Crohn’s disease-associated adherent-invasive Escherichia coli manipulate host autophagy by impairing SUMOylation. Cells, 8(1):35. [12]DemarqueMD, NacerddineK, Neyret-KahnH, et al., 2011. Sumoylation by Ubc9 regulates the stem cell compartment and structure and function of the intestinal epithelium in mice. Gastroenterology, 140(1):286-296. [13]DemetriouM, GranovskyM, QuagginS, et al., 2001. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature, 409(6821):733-739. [14]DiasAM, DouradoJ, LagoP, et al., 2014. Dysregulation of T cell receptor N-glycosylation: a molecular mechanism involved in ulcerative colitis. Hum Mol Genet, 23(9):2416-2427. [15]DiasAM, CorreiaA, PereiraMS, et al., 2018. Metabolic control of T cell immune response through glycans in inflammatory bowel disease. Proc Natl Acad Sci USA, 115(20):E4651-E4660. [16]DierckxT, VerstocktB, VermeireS, et al., 2019. GlycA, a nuclear magnetic resonance spectroscopy measure for protein glycosylation, is a viable biomarker for disease activity in IBD. J Crohns Colitis, 13(3):389-394. [17]DocenaG, RovedattiL, KruidenierL, et al., 2010. Down-regulation of p38 mitogen-activated protein kinase activation and proinflammatory cytokine production by mitogen-activated protein kinase inhibitors in inflammatory bowel disease. Clin Exp Immunol, 162(1):108-115. [18]EhrentrautSF, ColganSP, 2012. Implications of protein post-translational modifications in IBD. Inflamm Bowel Dis, 18(7):1378-1388. [19]EhrentrautSF, KominskyDJ, GloverLE, et al., 2013. Central role for endothelial human deneddylase-1/SENP8 in fine-tuning the vascular inflammatory response. J Immunol, 190(1):392-400. [20]EhrentrautSF, CurtisVF, WangRX, et al., 2016. Perturbation of neddylation-dependent NF-κB responses in the intestinal epithelium drives apoptosis and inhibits resolution of mucosal inflammation. Mol Biol Cell, 27(23):3687-3694. [21]EmbadeN, Fernández-RamosD, Varela-ReyM, et al., 2012. Murine double minute 2 regulates Hu antigen R stability in human liver and colon cancer through NEDDylation. Hepatology, 55(4):1237-1248. [22]EnchevRI, SchulmanBA, PeterM, 2015. Protein neddylation: beyond cullin-RING ligases. Nat Rev Mol Cell Biol, 16(1):30-44. [23]FlothoA, MelchiorF, 2013. Sumoylation: a regulatory protein modification in health and disease. Annu Rev Biochem, 82:357-385. [24]FosterSL, MedzhitovR, 2009. Gene-specific control of the TLR-induced inflammatory response. Clin Immunol, 130(1):7-15. [25]FritahS, LhocineN, GolebiowskiF, et al., 2014. Sumoylation controls host anti-bacterial response to the gut invasive pathogen Shigella flexneri. EMBO Rep, 15(9):965-972. [26]FujiiH, ShinzakiS, IijimaH, et al., 2016. Core fucosylation on T cells, required for activation of T-cell receptor signaling and induction of colitis in mice, is increased in patients with inflammatory bowel disease. Gastroenterology, 150(7):1620-1632. [27]FujimotoK, KinoshitaM, TanakaH, et al., 2017. Regulation of intestinal homeostasis by the ulcerative colitis-associated gene RNF186. Mucosal Immunol, 10(2):446-459. [28]GlorianV, AllègreJ, BertheletJ, et al., 2017. DNA damage and S phase-dependent E2F1 stabilization requires the cIAP1 E3-ubiquitin ligase and is associated with K63-poly-ubiquitination on lysine 161/164 residues. Cell Death Dis, 8(5):e2816. [29]GodbersenJC, HumphriesLA, DanilovaOV, et al., 2014. The Nedd8-activating enzyme inhibitor MLN4924 thwarts microenvironment-driven NF-κB activation and induces apoptosis in chronic lymphocytic leukemia B cells. Clin Cancer Res, 20(6):1576-1589. [30]GotoY, ObataT, KunisawaJ, et al., 2014. Innate lymphoid cells regulate intestinal epithelial cell glycosylation. Science, 345(6202):1254009. [31]GrigorianA, TorossianS, DemetriouM, 2009. T-cell growth, cell surface organization, and the galectin-glycoprotein lattice. Immunol Rev, 230(1):232-246. [32]GrigorianA, MkhikianH, DemetriouM, 2012. Interleukin-2, interleukin-7, T cell-mediated autoimmunity, and N-glycosylation. Ann N Y Acad Sci, 1253(1):49-57. [33]GrimmV, RiedelCU, 2016. Manipulation of the microbiota using probiotics. In: Schwiertz A (Ed.), Microbiota of the Human Body: Implications in Health and Disease. Springer, Cham, p.109-117. [34]GrootjansJ, KaserA, KaufmanRJ, et al., 2016. The unfolded protein response in immunity and inflammation. Nat Rev Immunol, 16(8):469-484. [35]HaglundK, DikicI, 2005. Ubiquitylation and cell signaling. EMBO J, 24(19):3353-3359. [36]HanK, WangQY, CaoHL, et al., 2016. The NEDD8-activating enzyme inhibitor MLN4924 induces G2 arrest and apoptosis in T-cell acute lymphoblastic leukemia. Oncotarget, 7(17):23812-23824. [37]HanZJ, FengYH, GuBH, et al., 2018. The post-translational modification, SUMOylation, and cancer (Review). Int J Oncol, 52(4):1081-1094. [38]HanićM, Trbojević-AkmačićI, LaucG, 2019. Inflammatory bowel disease—glycomics perspective. Biochim Biophys Acta Gen Subj, 1863(10):1595-1601. [39]HannounZ, MaarifiG, Chelbi-AlixMK, 2016. The implication of SUMO in intrinsic and innate immunity. Cytokine Growth Factor Rev, 29:3-16. [40]HayRT, 2005. SUMO: a history of modification. Mol Cell, 18(1):1-12. [41]HeML, TanB, VasanK, et al., 2017. SIRT1 and AMPK pathways are essential for the proliferation and survival of primary effusion lymphoma cells. J Pathol, 242(3):309-321. [42]HibberdAA, LyraA, OuwehandAC, et al., 2017. Intestinal microbiota is altered in patients with colon cancer and modified by probiotic intervention. BMJ Open Gastroenterol, 4(1):e000145. [43]HondaK, LittmanDR, 2016. The microbiota in adaptive immune homeostasis and disease. Nature, 535(7610):75-84. [44]HoriT, OsakaF, ChibaT, et al., 1999. Covalent modification of all members of human cullin family proteins by NEDD8. Oncogene, 18(48):6829-6834. [45]JohnsonJL, JonesMB, RyanSO, et al., 2013. The regulatory power of glycans and their binding partners in immunity. Trends Immunol, 34(6):290-298. [46]JoshiHJ, NarimatsuY, SchjoldagerKT, et al., 2018. SnapShot: O-glycosylation pathways across kingdoms. Cell, 172(3):632-632.e2. [47]KamitaniT, KitoK, NguyenHP, et al., 1997. Characterization of NEDD8, a developmentally down-regulated ubiquitin-like protein. J Biol Chem, 272(45):28557-28562. [48]KhouryJ, IblaJC, NeishAS, et al., 2007. Antiinflammatory adaptation to hypoxia through adenosine-mediated cullin-1 deneddylation. J Clin Invest, 117(3):703-711. [49]KimDY, KwonE, HartleyPD, et al., 2013. CBFβ stabilizes HIV Vif to counteract APOBEC3 at the expense of RUNX1 target gene expression. Mol Cell, 49(4):632-644. [50]KochS, NusratA, 2012. The life and death of epithelia during inflammation: lessons learned from the gut. Annu Rev Pathol Mech Dis, 7:35-60. [51]KominskyDJ, CampbellEL, ColganSP, 2010. Metabolic shifts in immunity and inflammation. J Immunol, 184(8):4062-4068. [52]KudelkaMR, StowellSR, CummingsRD, et al., 2020. Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD. Nat Rev Gastroenterol Hepatol, 17(10):597-617. [53]KumarA, WuHX, Collier-HyamsLS, et al., 2007. Commensal bacteria modulate cullin-dependent signaling via generation of reactive oxygen species. EMBO J, 26(21):4457-4466. [54]LetterioJJ, RobertsAB, 1998. Regulation of immune responses by TGF-β. Annu Rev Immunol, 16:137-161. [55]LiuJ, QianC, CaoXT, 2016. Post-translational modification control of innate immunity. Immunity, 45(1):15-30. [56]LiuZH, ShenTY, ZhangP, et al., 2010. Protective effects of Lactobacillus plantarum against epithelial barrier dysfunction of human colon cell line NCM460. World J Gastroenterol, 16(45):5759-5765. [57]LiuZH, ShenTY, ZhangP, et al., 2011a. Lactobacillus plantarum surface layer adhesive protein protects intestinal epithelial cells against tight junction injury induced by enteropathogenic Escherichia coli. Mol Biol Rep, 38(5):3471-3480. [58]LiuZH, ZhangP, MaYL, et al., 2011b. Lactobacillus plantarum prevents the development of colitis in IL-10-deficient mouse by reducing the intestinal permeability. Mol Biol Rep, 38(2):1353-1361. [59]MabbAM, MiyamotoS, 2007. SUMO and NF-κB ties. Cell Mol Life Sci, 64(15):1979-1996. [60]MajumdarD, TiernanJP, LoboAJ, et al., 2012. Keratins in colorectal epithelial function and disease. Int J Exp Pathol, 93(5):305-318. [61]MelhemH, HansmannelF, BressenotA, et al., 2016. Methyl-deficient diet promotes colitis and SIRT1-mediated endoplasmic reticulum stress. Gut, 65(4):595-606. [62]MengJ, LiuXG, ZhangP, et al., 2016. Rb selectively inhibits innate IFN-βproduction by enhancing deacetylation of IFN-βpromoter through HDAC1 and HDAC8. J Autoimmun, 73:42-53. [63]MilhollenMA, TraoreT, Adams-DuffyJ, et al., 2010. MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-κB-dependent lymphoma. Blood, 116(9):1515-1523. [64]MitchellJP, CarmodyRJ, 2018. NF-κB and the transcriptional control of inflammation. Int Rev Cell Mol Biol, 335:41-84. [65]MkhikianH, GrigorianA, LiCF, et al., 2011. Genetics and the environment converge to dysregulate N-glycosylation in multiple sclerosis. Nat Commun, 2:334. [66]MonteleoneG, KumberovaA, CroftNM, et al., 2001. Blocking Smad7 restores TGF-β1 signaling in chronic inflammatory bowel disease. J Clin Invest, 108(4):601-609. [67]MonteleoneG, PalloneF, MacDonaldTT, 2004. Smad7 in TGF-β-mediated negative regulation of gut inflammation. Trends Immunol, 25(10):513-517. [68]MonteleoneG, del Vecchio BlancoG, MonteleoneI, et al., 2005. Post-transcriptional regulation of Smad7 in the gut of patients with inflammatory bowel disease. Gastroenterology, 129(5):1420-1429. [69]MuniandyK, GothaiS, BadranKMH, et al., 2018. Suppression of proinflammatory cytokines and mediators in LPS-induced RAW 264.7 macrophages by stem extract of Alternanthera sessilis via the inhibition of the NF-κB pathway. J Immunol Res, 2018:3430684. [70]MustfaSA, SinghM, SuhailA, et al., 2017. SUMOylation pathway alteration coupled with downregulation of SUMO E2 enzyme at mucosal epithelium modulates inflammation in inflammatory bowel disease. Open Biol, 7(6):170024. [71]NavaP, KochS, LaukoetterMG, et al., 2010. Interferon-γregulates intestinal epithelial homeostasis through convergingβ-catenin signaling pathways. Immunity, 32(3):392-402. [72]NeishAS, GewirtzAT, ZengH, et al., 2000. Prokaryotic regulation of epithelial responses by inhibition of IκB-α ubiquitination. Science, 289(5484):1560-1563. [73]OvedS, MosessonY, ZwangY, et al., 2006. Conjugation to Nedd8 instigates ubiquitylation and down-regulation of activated receptor tyrosine kinases. J Biol Chem, 281(31):21640-21651. [74]PanZQ, KentsisA, DiasDC, et al., 2004. Nedd8 on cullin: building an expressway to protein destruction. Oncogene, 23(11):1985-1997. [75]PerdomoOJ, CavaillonJM, HuerreM, et al., 1994. Acute inflammation causes epithelial invasion and mucosal destruction in experimental shigellosis. J Exp Med, 180(4):1307-1319. [76]PereiraMS, AlvesI, VicenteM, et al., 2018. Glycans as key checkpoints of T cell activity and function. Front Immunol, 9:2754. [77]PorterAG, JänickeRU, 1999. Emerging roles of caspase-3 in apoptosis. Cell Death Differ, 6(2):99-104. [78]QinHL, ZhangZW, HangXM, et al., 2009. L. plantarum prevents Enteroinvasive Escherichia coli-induced tight junction proteins changes in intestinal epithelial cells. BMC Microbiol, 9:63. [79]RabutG, PeterM, 2008. Function and regulation of protein neddylation. EMBO Rep, 9(10):969-976. [80]RauschP, RehmanA, KünzelS, et al., 2011. Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (Secretor) genotype. Proc Natl Acad Sci USA, 108(47):19030-19035. [81]RazaA, CrothersJW, McGillMM, et al., 2017. Anti-inflammatory roles of p38α MAPK in macrophages are context dependent and require IL-10. J Leukoc Biol, 102(5):1219-1227. [82]RibetD, HamonM, GouinE, et al., 2010. Listeria monocytogenes impairs SUMOylation for efficient infection. Nature, 464(7292):1192-1195. [83]RodriguezRM, Lopez-LarreaC, Suarez-AlvarezB, 2015. Epigenetic dynamics during CD4+ T cells lineage commitment. Int J Biochem Cell Biol, 67:75-85. [84]RyanSO, CobbBA, 2012. Roles for major histocompatibility complex glycosylation in immune function. Semin Immunopathol, 34(3):425-441. [85]SaulVV, NiedenthalR, PichA, et al., 2015. SUMO modification of TBK1 at the adaptor-binding C-terminal coiled-coil domain contributes to its antiviral activity. Biochim Biophys Acta, 1853(1):136-143. [86]SchreinerP, NeurathMF, NgSC, et al., 2019. Mechanism-based treatment strategies for IBD: cytokines, cell adhesion molecules, JAK inhibitors, gut flora, and more. Inflamm Intest Dis, 4(3):79-96. [87]SchwechheimerC, 2018. NEDD8—its role in the regulation of Cullin-RING ligases. Curr Opin Plant Biol, 45:112-119. [88]SeddaS, FranzèE, BevivinoG, et al., 2018. Reciprocal regulation between Smad7 and Sirt1 in the gut. Front Immunol, 9:1854. [89]ShakespearMR, HaliliMA, IrvineKM, et al., 2011. Histone deacetylases as regulators of inflammation and immunity. Trends Immunol, 32(7):335-343. [90]SilvaJPB, Navegantes-LimaKC, OliveiraALB, et al., 2018. Protective mechanisms of butyrate on inflammatory bowel disease. Curr Pharm Des, 24(35):4154-4166. [91]ŠimurinaM, de HaanN, VučkovićF, et al., 2018. Glycosylation of immunoglobulin G associates with clinical features of inflammatory bowel diseases. Gastroenterology, 154(5):1320-1333.e10. [92]SinghAK, KhareP, ObaidA, et al., 2018. SUMOylation of ROR-γt inhibits IL-17 expression and inflammation via HDAC2. Nat Commun, 9:4515. [93]SinghUP, SinghNP, BusbeeB, et al., 2012. Alternative medicines as emerging therapies for inflammatory bowel diseases. Int Rev Immunol, 31(1):66-84. [94]SkellyMJ, MalikSI, le BihanT, et al., 2019. A role for S-nitrosylation of the SUMO-conjugating enzyme SCE1 in plant immunity. Proc Natl Acad Sci USA, 116(34):17090-17095. [95]SommerF, AdamN, JohanssonMEV, et al., 2014. Altered mucus glycosylation in core 1 O-glycan-deficient mice affects microbiota composition and intestinal architecture. PLoS ONE, 9(1):e85254. [96]SongH, HuaiWW, YuZX, et al., 2016. MLN4924, a first-in-class NEDD8-activating enzyme inhibitor, attenuates IFN-β production. J Immunol, 196(7):3117-3123. [97]SoucyTA, SmithPG, MilhollenMA, et al., 2009. An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature, 458(7239):732-736. [98]SrikanthB, VaidyaMM, KalraiyaRD, 2010. O-GlcNAcylation determines the solubility, filament organization, and stability of keratins 8 and 18. J Biol Chem, 285(44):34062-34071. [99]StickleNH, ChungJ, KlcoJM, et al., 2004. pVHL modification by NEDD8 is required for fibronectin matrix assembly and suppression of tumor development. Mol Cell Biol, 24(8):3251-3261. [100]SugiharaK, MorhardtTL, KamadaN, 2019. The role of dietary nutrients in inflammatory bowel disease. Front Immunol, 9:3183. [101]SuzukiK, YamadaT, YamazakiK, et al., 2018. Intestinal epithelial cell-specific deletion of α-mannosidase II ameliorates experimental colitis. Cell Struct Funct, 43(1):25-39. [102]TamirA, EichlerJ, 2017. N-glycosylation is important for proper Haloferax volcanii S-layer stability and function. Appl Environ Microbiol, 83(6):e03152-16. [103]TheodoratouE, CampbellH, VenthamNT, et al., 2014. The role of glycosylation in IBD. Nat Rev Gastroenterol Hepatol, 11(10):588-600. [104]TokuhiraN, KitagishiY, SuzukiM, et al., 2015. PI3K/AKT/PTEN pathway as a target for Crohn’s disease therapy (Review). Int J Mol Med, 35(1):10-16. [105]TsukamotoS, 2016. Search for inhibitors of the ubiquitin-proteasome system from natural sources for cancer therapy. Chem Pharm Bull, 64(2):112-118. [106]VeldhoenM, 2017. Interleukin 17 is a chief orchestrator of immunity. Nat Immunol, 18(6):612-621. [107]VenthamNT, KennedyNA, NimmoER, et al., 2013. Beyond gene discovery in inflammatory bowel disease: the emerging role of epigenetics. Gastroenterology, 145(2):293-308. [108]VerdinE, OttM, 2015. 50 years of protein acetylation: from gene regulation to epigenetics, metabolism and beyond. Nat Rev Mol Cell Biol, 16(4):258-264. [109]VerhelstX, DiasAM, ColombelJF, et al., 2020. Protein glycosylation as a diagnostic and prognostic marker of chronic inflammatory gastrointestinal and liver diseases. Gastroenterology, 158(1):95-110. [110]VermaS, MohapatraG, AhmadSM, et al., 2015. Salmonella engages host microRNAs to modulate SUMOylation: a new arsenal for intracellular survival. Mol Cell Biol, 35(17):2932-2946. [111]VermaV, CroleyF, SadanandomA, 2018. Fifty shades of SUMO: its role in immunity and at the fulcrum of the growth-defence balance. Mol Plant Pathol, 19(6):1537-1544. [112]WadzinskiTJ, SteinauerA, HieL, et al., 2018. Rapid phenolic O-glycosylation of small molecules and complex unprotected peptides in aqueous solvent. Nat Chem, 10(6):644-652. [113]WangGY, YuanJT, CaiX, et al., 2020. HucMSC-exosomes carrying miR-326 inhibit neddylation to relieve inflammatory bowel disease in mice. Clin Transl Med, 10(2):e113. [114]WangM, KaufmanRJ, 2016. Protein misfolding in the endoplasmic reticulum as a conduit to human disease. Nature, 529(7586):326-335. [115]WangR, WangGH, 2019. Protein modification and autophagy activation. In: Qin ZH (Ed.), Autophagy: Biology and Diseases: Basic Science. Springer, Singapore, p.237-259. [116]WeberA, WasiliewP, KrachtM, 2010. Interleukin-1 (IL-1) pathway. Sci Signal, 3(105):cm1. [117]WeiG, WeiL, ZhuJF, et al., 2009. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity, 30(1):155-167. [118]WolfertMA, BoonsGJ, 2013. Adaptive immune activation: glycosylation does matter. Nat Chem Biol, 9(12):776-784. [119]WuYB, QiuW, XuXW, et al., 2018. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate inflammatory bowel disease in mice through ubiquitination. Am J Transl Res, 10(7):2026-2036. [120]XiaPY, WangS, XiongZ, et al., 2015. IRTKS negatively regulates antiviral immunity through PCBP2 sumoylation-mediated MAVS degradation. Nat Commun, 6:8132. [121]XirodimasDP, SavilleMK, BourdonJC, et al., 2004. Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity. Cell, 118(1):83-97. [122]XirodimasDP, SundqvistA, NakamuraA, et al., 2008. Ribosomal proteins are targets for the NEDD8 pathway. EMBO Rep, 9(3):280-286. [123]YangY, GuanJ, ShaikhAS, et al., 2018. Histone acetyltransferase Mof affects the progression of DSS-induced colitis. Cell Physiol Biochem, 47(5):2159-2169. [124]YangYF, HeY, WangXX, et al., 2017. Protein SUMOylation modification and its associations with disease. Open Biol, 7(10):170167. [125]YavvariPS, VermaP, MustfaSA, et al., 2019. A nanogel based oral gene delivery system targeting SUMOylation machinery to combat gut inflammation. Nanoscale, 11(11):4970-4986. [126]YinMM, YanXB, WengWH, et al., 2018. Micro integral membrane protein (MIMP), a newly discovered anti-inflammatory protein of Lactobacillus plantarum, enhances the gut barrier and modulates microbiota and inflammatory cytokines. Cell Physiol Biochem, 45(2):474-490. [127]YouBH, ChaeHS, SongJ, et al., 2017. α-Mangostin ameliorates dextran sulfate sodium-induced colitis through inhibition of NF-κB and MAPK pathways. Int Immunopharmacol, 49:212-221. [128]ZhangMM, ZhouLX, WangYM, et al., 2019. Faecalibacterium prausnitzii produces butyrate to decrease c-Myc-related metabolism and Th17 differentiation by inhibiting histone deacetylase 3. Int Immunol, 31(8):499-514. [129]ZhangQ, ZhaoK, ShenQC, et al., 2015. Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6. Nature, 525(7569):389-393. [130]ZhaoYC, SunY, 2013. Cullin-RING ligases as attractive anti-cancer targets. Curr Pharm Des, 19(18):3215-3225. [131]ZhaoYC, MorganMA, SunY, 2014. Targeting neddylation pathways to inactivate cullin-RING ligases for anticancer therapy. Antioxid Redox Signal, 21(17):2383-2400. [132]ZhongXS, WinstonJH, LuoXJ, et al., 2018. Neonatal colonic inflammation epigenetically aggravates epithelial inflammatory responses to injury in adult life. Cell Mol Gastroenterol Hepatol, 6(1):65-78. Journal of Zhejiang University-SCIENCE, 38 Zheda Road, Hangzhou
310027, China
Tel: +86-571-87952783; E-mail: cjzhang@zju.edu.cn Copyright © 2000 - 2024 Journal of Zhejiang University-SCIENCE |
Open peer comments: Debate/Discuss/Question/Opinion
<1>